Effect of Early Empagliflozin Initiation in Cardiogenic Shock.

Clinical trial NCT07450417 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07450417
Sponsor: Central Hospital, Nancy, France
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Cardiogenic Shock

Start date: 2025-03-10
Primary completion: 2026-04-01
Enrollment: 418

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.